Alumiglassp. z o.o.
KRS: REGON:
Overview
Status
Active
Registry date
2003-01-06
Share capital
5,000.00 PLN
Registered address
Słowackiego 20 B, 58-300 Wałbrzych, Poland
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Wiesław Andrzej Wysoczańskiage 69 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Patrycja Kinga Hyziakage 48 | 100 | $1,350.62 | 100% |
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 9, 2020 | Dissolution without liquidation opened |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The company was registered in the Polish National Court Register (KRS) on January 6, 2003.
The headquarters is located at: Słowackiego 20 B, 58-300 Wałbrzych.
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-10-07